Identifing medical predictors of anti-hypertensive effect of eplerenone.

Trial Profile

Identifing medical predictors of anti-hypertensive effect of eplerenone.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms IMPRESSIVE
  • Most Recent Events

    • 15 Sep 2017 Status changed from recruiting to completed.
    • 04 Feb 2010 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 04 Feb 2010 Actual initiation date (Sep 2009) added as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top